Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shanghai Model Organisms Center (SHSE:688265) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Shanghai Model Organisms Center had a gross margin of 53.96% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Shanghai Model Organisms Center Gross Margin % Related Terms
Shanghai Model Organisms Center Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Model Organisms Center Gross Margin % Chart
SHSE:688265 vs VRTX, REGN, RVMD: Gross Margin % Comparison
For the Biotechnology subindustry, Shanghai Model Organisms Center's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Model Organisms Center Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Shanghai Model Organisms Center's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Shanghai Model Organisms Center's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Shanghai Model Organisms Center (SHSE:688265) has a Gross Margin % of 53.96% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Shanghai Model Organisms Center and its competitors. This is 11% above median its historical median of 48.62. Over the past decade, Shanghai Model Organisms Center's Gross Margin % has ranged from 41.74 to 64.86. According to the industry distribution chart, Shanghai Model Organisms Center ranks #427 out of 732 companies in the Biotechnology industry, placing it in the top 58.3%.
Is Shanghai Model Organisms Center's Gross Margin % too high?
Shanghai Model Organisms Center's current Gross Margin % of 53.96% is 11% above median its 10-year median of 48.62. Over the past 10 years, this metric has ranged from a low of 41.74 to a high of 64.86. The Biotechnology industry median Gross Margin % is 60.92. Shanghai Model Organisms Center's value of 53.96% is 11.4% below this industry median. Based on the distribution chart, Shanghai Model Organisms Center ranks #427 out of 732 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Shanghai Model Organisms Center has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Model Organisms Center's Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shanghai Model Organisms Center ranks #427 out of 732 companies for Gross Margin %. This places Shanghai Model Organisms Center in the lower half of its industry. The industry median Gross Margin % is 60.92. Shanghai Model Organisms Center's value of 53.96% is 11.4% below this benchmark. Historically, Shanghai Model Organisms Center's own Gross Margin % has ranged from 41.74 to 64.86 over the past decade. While the company's 10-year median is 48.62 vs. the industry median of 60.92, Shanghai Model Organisms Center has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.92, based on 732 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Model Organisms Center's current Gross Margin % of 53.96% is 11.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Shanghai Model Organisms Center and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Model Organisms Center's current Gross Margin % is 53.96%, which is 11% above median its own 10-year median of 48.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Model Organisms Center stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Model Organisms Center (SHSE:688265) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥47.95, compared to a current price of ¥32.31 — trading 32.6% below its estimated fair value. The current Gross Margin % is 53.96%, which is 11% above median its 10-year median of 48.62 and 11.4% below the Biotechnology industry median of 60.92. Shanghai Model Organisms Center's overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Shanghai Model Organisms Center (SHSE:688265), the current Gross Margin % is 53.96% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Model Organisms Center (SHSE:688265) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Model Organisms Center stock appears to be undervalued.
The current stock price of ¥32.31 is trading 32.6% below its estimated GF Value™ of ¥47.95.
GuruFocus considers Shanghai Model Organisms Center to be Significantly Undervalued.
Key valuation signals for SHSE:688265:
Gross Margin %: 53.96% (11% above median its 10-year median of 48.62)
GF Value™: ¥47.95 vs. price of ¥32.31 (32.6% below fair value)
Industry Position: 11.4% below the Biotechnology median (#427 of 732)
No single metric tells the full story. See the SHSE:688265 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Model Organisms Center Business Description
Shanghai Model Organisms Center Inc is engaged in model organisms and is dedicated to gene editing and life decoding. It provides customized solutions such as genetically engineered animal models, phenotype analysis and high-throughput screenings to advance life science research and drug discovery.
78GF Score
Get the complete analysis for SHSE:688265
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688265 has been successfully added to your 
